These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30392818)

  • 21. Component pathogen inactivation: a critical review.
    Prowse CV
    Vox Sang; 2013 Apr; 104(3):183-99. PubMed ID: 23134556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination.
    Santa Maria F; Laughhunn A; Lanteri MC; Aubry M; Musso D; Stassinopoulos A
    Transfusion; 2017 Aug; 57(8):2016-2025. PubMed ID: 28671343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols.
    Arbaeen AF; Schubert P; Serrano K; Carter CJ; Culibrk B; Devine DV
    Transfusion; 2017 May; 57(5):1208-1217. PubMed ID: 28236302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spotlight on platelets: summary of BBTS combined special interest group autumn meeting, November 2015.
    Murphy MF; Gill R; Moss R; Raghavan M; Stanworth SJ; Rowley M; Wallis J
    Transfus Med; 2016 Feb; 26(1):8-14. PubMed ID: 27061616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unresolved clinical aspects and safety hazards of blood derived- EV/MV in stored blood components: From personal memory lanes to newer perspectives on the roles of EV/MV in various biological phenomena.
    Seghatchian J; Amiral J
    Transfus Apher Sci; 2016 Aug; 55(1):10-22. PubMed ID: 27522103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.
    Johnson L; Winter KM; Reid S; Hartkopf-Theis T; Marschner S; Goodrich RP; Marks DC
    Vox Sang; 2011 Oct; 101(3):208-14. PubMed ID: 21492184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients.
    Saigo K; Sakota Y; Masuda Y; Matsunaga K; Takenokuchi M; Nishimura K; Sugimoto T; Sakurai K; Hashimoto M; Yanai T; Hayakawa A; Takeshima Y; Nomura T; Kubota Y; Kumagai S
    Transfus Apher Sci; 2008 Apr; 38(2):127-32. PubMed ID: 18331815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The platelet storage lesion.
    Devine DV; Serrano K
    Clin Lab Med; 2010 Jun; 30(2):475-87. PubMed ID: 20513565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shared decision-making, gender and new technologies.
    Zeiler K
    Med Health Care Philos; 2007 Sep; 10(3):279-87. PubMed ID: 17203362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet monitoring follow-up in a pregnant patient with HELLP syndrome.
    Kuiper GJ; Lancé MD; Smit-Fun VM; Peeters LL; Marcus MA
    Platelets; 2011; 22(2):160-3. PubMed ID: 21142407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R; Fröhlich A; Mayaudon V; Lin L
    J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion.
    Sonego G; Abonnenc M; Tissot JD; Prudent M; Lion N
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Expression Analysis by RNA-Seq Reveals Perturbations in the Platelet mRNA Transcriptome Triggered by Pathogen Reduction Systems.
    Osman A; Hitzler WE; Ameur A; Provost P
    PLoS One; 2015; 10(7):e0133070. PubMed ID: 26172280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomolecular Consequences of Platelet Pathogen Inactivation Methods.
    Feys HB; Van Aelst B; Compernolle V
    Transfus Med Rev; 2019 Jan; 33(1):29-34. PubMed ID: 30021699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultraviolet light-based pathogen inactivation and alloimmunization after platelet transfusion: results from a randomized trial.
    Norris PJ; Kaidarova Z; Maiorana E; Milani S; Lebedeva M; Busch MP; Custer B; Rebulla P
    Transfusion; 2018 May; 58(5):1210-1217. PubMed ID: 29473173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period.
    Cazenave JP; Isola H; Waller C; Mendel I; Kientz D; Laforêt M; Raidot JP; Kandel G; Wiesel ML; Corash L
    Transfusion; 2011 Mar; 51(3):622-9. PubMed ID: 20849406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hemostatic efficacy of platelet components prepared with pathogen inactivation.
    Corash L
    Transfusion; 2011 Jun; 51(6):1355-6; author reply 1356-7. PubMed ID: 21658040
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.
    Picker SM; Schneider V; Gathof BS
    Transfusion; 2009 Jun; 49(6):1224-32. PubMed ID: 19220821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light.
    Bakkour S; Chafets DM; Wen L; van der Meer PF; Mundt JM; Marschner S; Goodrich RP; Busch MP; Lee TH
    Vox Sang; 2014 Nov; 107(4):351-9. PubMed ID: 24976130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.